跳至主要内容
临床试验/NCT00537550
NCT00537550已完成不适用

GIMEMA Guidelines for the Treatment of Adult ALL Affected Patients at Diagnosis

Gruppo Italiano Malattie EMatologiche dell'Adulto5 个研究点 分布在 1 个国家开始时间: 2000年7月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
试验地点
5

研究概览

简要总结

The present study has been designed to give participating centers the possibility of better understanding the diagnostic and prognostic factors of ALL patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
14 Years 至 60 Years(Child, Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Diagnosis of acute lymphoblastic leukemia (ALL)
  • •Negative myeloperoxidase stain
  • •Phenotype T (ALL-T) and B(ALL-B)

排除标准

  • •Creatinine > 2.5mg/dL after adequate hydratation
  • •LVEF <50%
  • •Presence of documented infections not responding to antibiotic and/or antifungal therapy
  • •Presence of concomitant malignant diseases
  • •Absence of any psychological condition that does not allow to intake high doses of cortisone
  • •Patients who have received any antineoplastic chemiotherapy for more than 5 days
  • •Patients who have received any steroids for more than 10 days

研究者

研究点 (5)

Loading locations...

相似试验

Adult ALL Treatment at Diagnosis | 临床试验